Pattern and Management of Intracranial Cavernoma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04181086|
Recruitment Status : Unknown
Verified November 2019 by Moataz Elshenawi, Assiut University.
Recruitment status was: Not yet recruiting
First Posted : November 29, 2019
Last Update Posted : November 29, 2019
|Condition or disease||Intervention/treatment|
|Management of Intracranial Cavernous Hemangioma||Procedure: surgical excision of intracranial cavernoma|
|Study Type :||Observational|
|Estimated Enrollment :||35 participants|
|Official Title:||Pattern and Management of Intracranial Cavernoma|
|Estimated Study Start Date :||January 1, 2020|
|Estimated Primary Completion Date :||June 1, 2021|
|Estimated Study Completion Date :||January 1, 2022|
- Procedure: surgical excision of intracranial cavernoma
microvascular excision of intracranial cavernoma
- clinical outcome [ Time Frame: one month post operative ]
Measured by Modified Rankin Scale Measures the degree of disability or dependence in the daily activities of people who have suffered any cause of neurological disability.
The scale runs from 0-6, running from perfect health without symptoms to death.
0 - No symptoms.
- - No significant disability. Able to carry out all usual activities, despite some symptoms.
- - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities.
- - Moderate disability. Requires some help, but able to walk unassisted.
- - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted.
- - Severe disability. Requires constant nursing care and attention, bedridden, incontinent.
- - Dead.